Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
electroCore, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
ECOR
Nasdaq
3841
https://www.electrocore.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for electroCore, Inc.
electroCore, Inc. (NASDAQ:ECOR) Q4 2023 Earnings Call Transcript
- Mar 16th, 2024 6:15 pm
Q4 2023 electroCore, Inc. Earnings Call
- Mar 14th, 2024 10:19 am
ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
- Mar 13th, 2024 9:25 pm
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
- Mar 13th, 2024 8:05 pm
electroCore to Participate in Upcoming Investor Conferences
- Mar 12th, 2024 12:00 pm
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
- Mar 5th, 2024 9:05 pm
electroCore Expands Intellectual Property Portfolio
- Feb 6th, 2024 1:00 pm
These Stocks under $10 Are Poised To Explode
- Dec 21st, 2023 9:13 pm
electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology
- Dec 12th, 2023 1:00 pm
Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023
- Nov 15th, 2023 1:15 pm
electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript
- Nov 9th, 2023 6:17 pm
electroCore Inc (ECOR) Reports Substantial Sales Growth in Q3 2023
- Nov 8th, 2023 11:29 pm
electroCore Announces Third Quarter 2023 Financial Results
- Nov 8th, 2023 9:01 pm
electroCore to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
- Nov 7th, 2023 1:00 pm
Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting
- Oct 24th, 2023 12:00 pm
electroCore Announces Two-Year Extension of gammaCore™ Device Listing in the NHS Supply Chain Catalogue
- Oct 17th, 2023 12:00 pm
electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology
- Oct 11th, 2023 12:00 pm
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress
- Oct 10th, 2023 12:00 pm
electroCore to Announce Third Quarter Financial Results on Wednesday, November 8
- Oct 9th, 2023 12:00 pm
electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference
- Oct 5th, 2023 12:00 pm
Scroll